sodium iodide [123i] injection curiumpharma 37 mbq/ ml
curium netherlands b.v. - natriumjodid (123i) - injeksjonsvæske, oppløsning - 37 mbq/ ml
sodium iodide [131i] capsules t curiumpharma -
curium netherlands b.v. - natriumjodid (131i) - kapsel, hard
bencium 500 mg / 800 iu
consilient health limited - kalsiumkarbonat / kolekalsiferol - tyggetablett med appelsinsmak - 500 mg / 800 iu
bencium 500 mg / 2000 iu
consilient health ltd. - kalsiumkarbonat / kolekalsiferol - tyggetablett med appelsinsmak - 500 mg / 2000 iu
cisatracurium kalceks 2 mg/ ml
akciju sabiedriba kalceks - cisatrakuriumbesilat - injeksjons-/infusjonsvæske, oppløsning - 2 mg/ ml
mibg [123i] 74 mbq/ ml
curium netherlands b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml
pylclari
curium pet france - piflufolastat (18f) - prostata neoplasmer - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
indium [111in] oxinate 37 mbq/ ml
curium netherlands b.v. - indium (111in) oksin - oppløsning - 37 mbq/ ml
thallous (201ti) chloride 37 mbq/ ml
curium netherlands b.v. - talliumklorid (201tl) - injeksjonsvæske, oppløsning - 37 mbq/ ml
indium [111in] dtpa 37 mbq/ ml
curium netherlands b.v. - indium (111in) pentetat - injeksjonsvæske, oppløsning - 37 mbq/ ml